DPP4 and anaplastic large cell lymphoma: In hematological neoplasms, CD26 expression confers proliferative advantages or invasive properties in T-cell lymphoblastic lymphoma (LBL)/lymphoblastic leukemia, T-anaplastic large cell lymphoma (ALCL), and T-large granular lymphocyte lymphoproliferative disorder (T-LGL LPD)45–47.